Logo
R

Ronawk LLC

8 employees

Ronawk develops a T-Block technology producing patient-specific biologics to treat diseases, cancer, organ injuries, and burns.

Basic info

Industry

biotechnology research

Sectors

Cellular Reprogramming
Animal Healthcare
Biotechnology
Analytical Imaging
3D Bioprinting
Biopharma
Tissue Engineering
Health Care
Agriculture
Human Healthcare
Biological Characterization
Personalized Medicine
Life Sciences
Cell Expansion
Stem Cells
Contract Research Organization

Date founded

2019

Funding rounds raised

Total raised

$1.5M

from 1 investors over 1 rounds

R

Ronawk LLC raised $1.5M on July 7, 2022

Investors: Accelerate Venture Partners

FAQ